Published in Nord Med on January 01, 1989
The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis. Mult Scler (2013) 5.40
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet (2001) 4.55
Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology (2012) 2.54
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis. Neurology (2006) 2.24
Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochir (Wien) (1990) 1.88
Essential tremor treated with propranolol: lack of correlation between clinical effect and plasma propranolol levels. Ann Neurol (1981) 1.75
Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke (1988) 1.74
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology (2009) 1.59
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler (2009) 1.56
Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results. Mult Scler (2008) 1.49
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Mult Scler (2008) 1.42
[Surgical treatment of epilepsy resistant to drug therapy. A review]. Ugeskr Laeger (1991) 1.38
Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys (2000) 1.37
Bone lesions in early syphilis detected by bone scintigraphy. Br J Vener Dis (1984) 1.35
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses. Eur J Neurol (2005) 1.20
The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society. BJU Int (2002) 1.14
Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group. Ann Neurol (2000) 1.14
Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology (2000) 1.13
The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun (2001) 1.11
Danish very-low-dose aspirin after carotid endarterectomy trial. Stroke (1988) 1.10
Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting. J Neurosurg (1987) 1.10
Intracranial pressure and cerebrospinal fluid outflow conductance in healthy subjects. J Neurosurg (1991) 1.09
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis. Acta Neurol Scand (2012) 1.05
The six spot step test: a new measurement for walking ability in multiple sclerosis. Mult Scler (2006) 1.05
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development. Mult Scler (2013) 1.03
The incidence and clinical presentation of neurosyphilis in Greater Copenhagen 1974 through 1978. Acta Neurol Scand (1981) 1.01
Familial effects on the clinical course of multiple sclerosis. Neurology (2007) 1.00
High cerebrospinal fluid concentration of glial fibrillary acidic protein (GFAP) in patients with normal pressure hydrocephalus. J Neurol Sci (1985) 0.97
A prospective study of 39 patients with whiplash injury. Acta Neurol Scand (1997) 0.95
Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients. Eur J Cancer (1994) 0.95
The efficacy of multidisciplinary rehabilitation in stable multiple sclerosis patients. Mult Scler (2006) 0.94
Autosomal dominant pure spastic paraplegia: a clinical, paraclinical, and genetic study. J Neurol Neurosurg Psychiatry (1998) 0.93
Correlations of brain MRI parameters to disability in multiple sclerosis. Acta Neurol Scand (2001) 0.93
Sleep disturbances in critically ill patients in ICU: how much do we know? Acta Anaesthesiol Scand (2012) 0.93
Nocturia in women. Am J Obstet Gynecol (2001) 0.92
Pathophysiological aspects of nocturia in a danish population of men and women age 60 to 80 years. J Urol (2007) 0.92
Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. J Neurol Neurosurg Psychiatry (1985) 0.91
The diagnostic reliability of magnetically evoked motor potentials in multiple sclerosis. Neurology (1992) 0.91
Cerebrospinal fluid vasopressin and increased intracranial pressure. Ann Neurol (1984) 0.90
Sleep disturbances after fast-track hip and knee arthroplasty. Br J Anaesth (2012) 0.89
A computer-based information system for epilepsy and electroencephalography. Int J Med Inform (1999) 0.89
Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate. Mult Scler (2000) 0.87
Physical activity maintenance in patients with rheumatoid arthritis: a qualitative study. Clin Rehabil (2013) 0.87
Effect of baclofen on gait in spastic MS patients. Acta Neurol Scand (2000) 0.87
Pathology of skeletal muscle in fibromyalgia: a histo-immuno-chemical and ultrastructural study. Br J Rheumatol (1993) 0.87
Long-term prognosis after transient ischemic attacks. Acta Neurol Scand (1981) 0.87
Prediction of response to interferon therapy in multiple sclerosis. Acta Neurol Scand (2014) 0.87
Measurement of blood flow in the superior sagittal sinus in healthy volunteers, and in patients with normal pressure hydrocephalus and idiopathic intracranial hypertension with phase-contrast cine MR imaging. Acta Radiol (1996) 0.85
Cognitive deficits in multiple sclerosis: correlations with T2 changes in normal appearing brain tissue. Acta Neurol Scand (2011) 0.85
Resistance to cerebrospinal fluid outflow and intracranial pressure in patients with hydrocephalus after subarachnoid haemorrhage. Acta Neurochir (Wien) (1987) 0.85
Absence of hydrocephalus in spite of impaired cerebrospinal fluid absorption and severe intracranial hypertension. Acta Neurochir (Wien) (1987) 0.84
Assessment of CSF dynamics and venous flow in the superior sagittal sinus by MRI in idiopathic intracranial hypertension: a preliminary study. Neuroradiology (1994) 0.84
Cerebrospinal fluid flow and production in patients with normal pressure hydrocephalus studied by MRI. Neuroradiology (1994) 0.84
Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol (1991) 0.84
Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis. Mult Scler (2012) 0.84
Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis. Genes Immun (2009) 0.83
Transient ischaemic attacks in young patients: a thromboembolic or migrainous manifestation? A 10 year follow up study of 46 patients. J Neurol Neurosurg Psychiatry (1990) 0.83
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis. Clin Exp Immunol (2012) 0.83
Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients. Eur J Neurol (2012) 0.82
CSF-amine metabolites in depression, dementia and in controls. Acta Psychiatr Scand (1987) 0.82
Increased brain water self-diffusion in patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol (1995) 0.82
Medico-legal implications of sleep apnoea syndrome: driving license regulations in Europe. Sleep Med (2007) 0.82
Cerebral metabolism in a case of multiple sclerosis with acute mental disorder. Acta Neurol Scand (1996) 0.81
Metastatic spinal cord compression secondary to lung cancer. J Clin Oncol (1992) 0.81
Using measurements of neutralizing antibodies: the challenge of IFN-beta therapy. Eur J Neurol (2007) 0.81
Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population. Eur Urol (2006) 0.81
Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentrations at brain level? Acta Neurochir (Wien) (1988) 0.81
Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension. Acta Endocrinol (Copenh) (1982) 0.81
Second occurrence of symptomatic metastatic spinal cord compression and findings of multiple spinal epidural metastases. Int J Radiat Oncol Biol Phys (1995) 0.80
Anal sphincter EMG in the diagnosis of parkinsonian syndromes. Acta Neurol Scand (2009) 0.80
Gender effects on treatment response to interferon-beta in multiple sclerosis. Acta Neurol Scand (2014) 0.80
The Danish National Project of interferon-beta treatment in relapsing-remitting multiple sclerosis. The Danish Multiple Sclerosis Group. Mult Scler (2000) 0.80
A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. Neurology (1999) 0.80
Diagnostic value of spinal computer tomography in patients with intraspinal metastases causing complete block on myelography. Acta Radiol (1991) 0.80
CSF and plasma vasopressin concentrations in dementia. J Neurol Neurosurg Psychiatry (1983) 0.80
Morbidity of urodynamic investigation in healthy women. Int Urogynecol J Pelvic Floor Dysfunct (2002) 0.79
A case of malignant lymphoma and myasthenia gravis. Scand J Haematol (1983) 0.79
Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis. Mult Scler (2011) 0.79
[Metastatic spinal compression syndrome. Symptoms, diagnosis, treatment and prognosis]. Ugeskr Laeger (1990) 0.79
High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety, and absorption of selenium. Biol Trace Elem Res (1990) 0.79
Visual evoked potentials in pseudotumor cerebri. Arch Neurol (1985) 0.79
Sexual dysfunction in male and female patients with epilepsy: a study of 86 outpatients. Arch Sex Behav (1990) 0.79
Persistent disturbances of cognitive functions in patients with pseudotumor cerebri. Acta Neurol Scand (1986) 0.79
Increased intracortical facilitation in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p. Eur J Neurol (2001) 0.79
Studies of vasopressin in the human cerebrospinal fluid. Acta Neurol Scand (1986) 0.78
A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine. Cephalalgia (1986) 0.78
Increased self-diffusion of brain water in hydrocephalus measured by MR imaging. Acta Radiol (1994) 0.77
Middle fossa approach in vestibular schwannoma surgery. Postoperative hearing preservation and EEG changes. Acta Otolaryngol (2000) 0.77
Severe headache as the only symptom of long-standing shunt dysfunction in hydrocephalic children with normal or slit ventricles revealed by computed tomography. Childs Nerv Syst (1985) 0.77
Cerebrospinal fluid vasopressin in benign intracranial hypertension. Neurology (1982) 0.77
Evaluation of electronic equipment for quantitative registration of tremor. Acta Neurol Scand (1998) 0.77
Language function following subdural grid-directed temporal lobectomy. Acta Neurol Scand (1994) 0.77
Vasopressin in plasma and ventricular cerebrospinal fluid during dehydration, postural changes, and nausea. Am J Physiol (1985) 0.77
Vasopressin release during electroconvulsive therapy. Psychoneuroendocrinology (1982) 0.77
Comparison of myelography combined with postmyelographic spinal CT and MRI in suspected metastatic disease of the spinal canal. J Neurooncol (1992) 0.77
Therapeutic interference with leukocyte recirculation in multiple sclerosis. Eur J Neurol (2015) 0.77